Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Anna M Czarnecka
An Update on the Safety of Nivolumab for the Treatment of Advanced Melanoma
Expert Opinion on Drug Safety
Medicine
Pharmacology
Related publications
Ipilimumab Combined With Nivolumab: A Standard of Care for the Treatment of Advanced Melanoma?
Clinical Cancer Research
Cancer Research
Oncology
P2.44: An Update of a Pooled Analysis of Nivolumab for the Treatment of Advanced NSCLC and the Role of PD-L1 as a BIOMARKER
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Nivolumab in the Treatment of Advanced Renal Cell Carcinoma
Oncology in Clinical Practice
Oncology
Eribulin for the Treatment of Metastatic Breast Cancer: An Update on Its Safety and Efficacy
International Journal of Women's Health
Gynecology
Oncology
Midwifery
Maternity
Obstetrics
Pcn184 - Cost-Effectiveness of Nivolumab Plus Ipilimumab in Advanced Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
An Update on BRAF Inhibitors and Other New Molecular Targets for the Treatment of Malignant Melanoma of the Skin
Clinical Medicine Insights: Dermatology
An Update on the Society for Immunotherapy of Cancer Consensus Statement on Tumor Immunotherapy for the Treatment of Cutaneous Melanoma: Version 2.0
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Pcn36 - The Effect of Introducing Nivolumab in the Adjuvant Treatment Setting of Malignant Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
